RECURRENT WALDENSTROM MACROGLOBULINEMIA
Clinical trials for RECURRENT WALDENSTROM MACROGLOBULINEMIA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT WALDENSTROM MACROGLOBULINEMIA trials appear
Sign up with your email to follow new studies for RECURRENT WALDENSTROM MACROGLOBULINEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy offers hope for Tough-to-Treat lymphomas
Disease control OngoingThis study tests a combination of two drugs—nivolumab and lenalidomide—in people with non-Hodgkin or Hodgkin lymphoma that has returned or stopped responding to treatment. The goal is to find the safest dose and see how well the drugs work together. About 36 adults with specific …
Matched conditions: RECURRENT WALDENSTROM MACROGLOBULINEMIA
Phase: PHASE1, PHASE2 • Sponsor: David Bond, MD • Aim: Disease control
Last updated May 26, 2026 08:29 UTC
-
New drug combo shows promise for tough lymphoma
Disease control OngoingThis study tests adding an experimental drug called selinexor to the standard chemotherapy R-CHOP for people with B-cell non-Hodgkin lymphoma. The goal is to find the safest dose and see if the combination works better than standard treatment alone. About 43 adults with advanced …
Matched conditions: RECURRENT WALDENSTROM MACROGLOBULINEMIA
Phase: PHASE1, PHASE2 • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control
Last updated May 22, 2026 13:52 UTC